<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-03-30753">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2003_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-23</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Medicare Program; Medicare Prescription Drug Discount Card</title>
        <partNumber>Part III</partNumber>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2003-12-15/html/03-30753.htm">
        <identifier type="FDsys Unique ID">D09002ee1c816bf78</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2003-12-15/pdf/03-30753.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c816c04b</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Centers for Medicare &amp; Medicaid Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>Section 101, subpart 4 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, codified in section 1860D- 31 of the Social Security Act, provides for a voluntary prescription drug discount card program for Medicare beneficiaries entitled to benefits, or enrolled, under Part A or enrolled under Part B, excluding beneficiaries entitled to medical assistance for outpatient prescription drugs under Medicaid, including section 1115 waiver demonstrations. Eligible beneficiaries may access negotiated prices on prescription drugs by enrolling in drug discount card programs offered by Medicare-endorsed sponsors. Eligible beneficiaries may enroll in the Medicare drug discount card program beginning no later than 6 months after the date of enactment of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and ending December 31, 2005. After December 31, 2005, beneficiaries enrolled in the program may continue to use their drug discount card during a short transition period beginning January 1, 2006 and ending upon the effective date of a beneficiary's outpatient drug coverage under Medicare Part D, but no later than the last day of the initial open enrollment period under Part D. Beneficiaries with incomes no more than 135 percent of the poverty line applicable to their family size who do not have outpatient prescription drug coverage under certain programs--Medicaid, certain health insurance coverage or group health insurance (such as retiree coverage), TRICARE, and Federal Employees Health Benefits Program (FEHBP)--also are eligible for transitional assistance, or payment of $600 in 2004 and up to $600 in 2005 of the cost of covered discount card drugs obtained under the program. In most cases, any transitional assistance remaining available to a beneficiary on December 31, 2004 may be rolled over to 2005 and applied toward the cost of covered discount card drugs obtained under the program during 2005. Similarly, in most cases, any transitional assistance remaining available to a beneficiary on December 31, 2005 may be applied toward the cost of covered discount card drugs obtained under the program during the transition period. The Centers for Medicare &amp; Medicaid Services will solicit applications from entities seeking to offer beneficiaries negotiated prices on covered discount card drugs. Those meeting the requirements described in the authorizing statute and this rule, including administration of transitional assistance, will be permitted to offer a Medicare-endorsed drug discount card program to eligible beneficiaries. Endorsed sponsors may charge beneficiaries enrolling in their endorsed programs an annual enrollment fee for 2004 and 2005 of no more than $30; CMS will pay this fee on behalf of enrollees entitled to transitional assistance. To ensure that eligible Medicare beneficiaries take full advantage of the Medicare drug discount card program and make informed choices, CMS will educate beneficiaries about the existence and features of the program and the availability of transitional assistance for certain low-income beneficiaries; and publicize information that will allow Medicare beneficiaries to compare the various Medicare-endorsed drug discount card programs.</abstract>
    <identifier type="FR citation">68 FR 69840</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2003-12-15/03-30753</identifier>
    <identifier type="FR Doc No.">03-30753</identifier>
    <identifier type="former granule identifier">fr15de03-20</identifier>
    <identifier type="Regulation ID Number">RIN 0938-AM71</identifier>
    <identifier type="billing code">4120-01-P</identifier>
    <identifier type="department code">CMS-4063-IFC</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2003-12-15/03-30753</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2003-12-15/html/03-30753.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2003-12-15/pdf/03-30753.pdf</url>
    </location>
    <subject>
        <topic>Grant Programs-Health</topic>
        <topic>Health Insurance</topic>
        <topic>Hospitals</topic>
        <topic>Intergovernmental Relations</topic>
        <topic>Medicare</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
    </subject>
    <physicalDescription>
        <extent>88 p.</extent>
    </physicalDescription>
    <part type="Part III">
        <extent unit="pages">
            <start>69840</start>
            <end>69927</end>
        </extent>
    </part>
    <identifier type="preferred citation">68 FR 69840</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 42 Part 403</partNumber>
        </titleInfo>
        <identifier type="CFR citation">42 CFR Part  403</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 42 Part 408</partNumber>
        </titleInfo>
        <identifier type="CFR citation">42 CFR Part  408</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 0938-AM71</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 0938-AM71</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Medicare Program; Medicare Prescription Drug Discount Card; Federal Register Vol. 68, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>03-30753</accessId>
        <partNumber>III</partNumber>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Centers for Medicare &amp; Medicaid Services</agency>
        <departmentDoc>CMS-4063-IFC</departmentDoc>
        <rin number="0938-AM71"/>
        <billingCode>4120-01-P</billingCode>
        <frDocNumber>03-30753</frDocNumber>
        <action>Interim final rule with comment period.</action>
        <summary>Section 101, subpart 4 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, codified in section 1860D- 31 of the Social Security Act, provides for a voluntary prescription drug discount card program for Medicare beneficiaries entitled to benefits, or enrolled, under Part A or enrolled under Part B, excluding beneficiaries entitled to medical assistance for outpatient prescription drugs under Medicaid, including section 1115 waiver demonstrations. Eligible beneficiaries may access negotiated prices on prescription drugs by enrolling in drug discount card programs offered by Medicare-endorsed sponsors. Eligible beneficiaries may enroll in the Medicare drug discount card program beginning no later than 6 months after the date of enactment of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and ending December 31, 2005. After December 31, 2005, beneficiaries enrolled in the program may continue to use their drug discount card during a short transition period beginning January 1, 2006 and ending upon the effective date of a beneficiary's outpatient drug coverage under Medicare Part D, but no later than the last day of the initial open enrollment period under Part D. Beneficiaries with incomes no more than 135 percent of the poverty line applicable to their family size who do not have outpatient prescription drug coverage under certain programs--Medicaid, certain health insurance coverage or group health insurance (such as retiree coverage), TRICARE, and Federal Employees Health Benefits Program (FEHBP)--also are eligible for transitional assistance, or payment of $600 in 2004 and up to $600 in 2005 of the cost of covered discount card drugs obtained under the program. In most cases, any transitional assistance remaining available to a beneficiary on December 31, 2004 may be rolled over to 2005 and applied toward the cost of covered discount card drugs obtained under the program during 2005. Similarly, in most cases, any transitional assistance remaining available to a beneficiary on December 31, 2005 may be applied toward the cost of covered discount card drugs obtained under the program during the transition period. The Centers for Medicare &amp; Medicaid Services will solicit applications from entities seeking to offer beneficiaries negotiated prices on covered discount card drugs. Those meeting the requirements described in the authorizing statute and this rule, including administration of transitional assistance, will be permitted to offer a Medicare-endorsed drug discount card program to eligible beneficiaries. Endorsed sponsors may charge beneficiaries enrolling in their endorsed programs an annual enrollment fee for 2004 and 2005 of no more than $30; CMS will pay this fee on behalf of enrollees entitled to transitional assistance. To ensure that eligible Medicare beneficiaries take full advantage of the Medicare drug discount card program and make informed choices, CMS will educate beneficiaries about the existence and features of the program and the availability of transitional assistance for certain low-income beneficiaries; and publicize information that will allow Medicare beneficiaries to compare the various Medicare-endorsed drug discount card programs.</summary>
        <dates>Effective Date: The provisions of this interim final rule with comment period are effective December 15, 2003.</dates>
        <contact>Teresa DeCaro, (410) 786-6604.</contact>
        <cfr title="42">
                                    
            <part number="403"/>
                                    
            <subject>Grant Programs-Health</subject>
                                    
            <subject>Health Insurance</subject>
                                    
            <subject>Hospitals</subject>
                                    
            <subject>Intergovernmental Relations</subject>
                                    
            <subject>Medicare</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <cfr title="42">
                                    
            <part number="408"/>
                                
        </cfr>
        <tocSubject1>Medicare</tocSubject1>
        <tocDoc>Prescription drug discount card, </tocDoc>
        <urlRef>http://hhs.gov/ocr/hipaa</urlRef>
        <urlRef>http://www.access.gpo.gov/nara/index.html</urlRef>
        <urlRef>http://www.cms.hhs.gov/publications/trusteesreport/2003/</urlRef>
        <urlRef>http://www.cms.hhs.gov/statistics/nhe/projections-2002/t11.asp</urlRef>
        <urlRef>http://www.medicare.gov</urlRef>
        <urlRef>http://www.nacds.org</urlRef>
        <urlRef>http://www.sba.gov/size/naicstb2-ret.html</urlRef>
        <urlRef>www.oig.hhs.gov/fraud/advisoryopinions.html</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1809c5c24" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2003-12-15/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 68, no. 240</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2003-12-15</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>369 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2003-12-15">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2003-12-15</identifier>
        <identifier type="local">P0b002ee1809c5c24</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr15de03</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2003-12-15</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2003-12-15/pdf/FR-2003-12-15.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2003-12-15/xml/FR-2003-12-15.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>69583</start>
                <end>69939</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-23</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-07</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2003-12-15</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2003-12-15</accessId>
            <volume>68</volume>
            <issue>240</issue>
        </extension>
    </relatedItem>
</mods>
